BrainStorm seeks early approval for stem cell treatment in Canada – Reuters
|
BrainStorm seeks early approval for stem cell treatment in Canada
Reuters TEL AVIV Israel's BrainStorm Cell Therapeutics is seeking early approval in Canada for its adult stem cell treatment for patients with amyotrophic lateral sclerosis (ALS), a neuro-degenerative disease, even before it completes late-stage clinical trials. |
